<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:ali="http://www.niso.org/schemas/ali/1.0" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="case-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">An Bras Dermatol</journal-id>
      <journal-id journal-id-type="iso-abbrev">An Bras Dermatol</journal-id>
      <journal-title-group>
        <journal-title>Anais Brasileiros de Dermatologia</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">0365-0596</issn>
      <issn pub-type="epub">1806-4841</issn>
      <publisher>
        <publisher-name>Sociedade Brasileira de Dermatologia</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">26375226</article-id>
      <article-id pub-id-type="pmc">4560546</article-id>
      <article-id pub-id-type="doi">10.1590/abd1806-4841.20153256</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Acute generalized exanthematous pustulosis x Von Zumbusch&#x2019;s pustular
psoriasis: A diagnostic challenge in a psoriatic patient<xref ref-type="fn" rid="fn01">*</xref></article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name>
            <surname>de Sousa</surname>
            <given-names>Aline Soares</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
          <xref ref-type="corresp" rid="c01"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Lara</surname>
            <given-names>Os&#xF3;rio Alves Corr&#xEA;a de Castro</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Papaiordanou</surname>
            <given-names>Francine</given-names>
          </name>
          <xref ref-type="aff" rid="aff02">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Marchioro</surname>
            <given-names>Gl&#xE1;ucia Silva Simioni</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Tebcherani</surname>
            <given-names>Antonio Jos&#xE9;</given-names>
          </name>
          <xref ref-type="aff" rid="aff01">1</xref>
        </contrib>
      </contrib-group>
      <aff id="aff01"><label>1</label> Complexo Hospitalar Padre Bento de Guarulhos (CHPBG) -
Guarulhos (SP), Brazil.</aff>
      <aff id="aff02"><label>2</label> Instituto de Dermatologia Prof. Rubem David Azulay - Santa
Casa da Miseric&#xF3;rdia do Rio de Janeiro - Rio de Janeiro (RJ), Brazil.</aff>
      <author-notes>
        <corresp id="c01">MAILING ADDRESS: Francine Papaiordanou, Av. Em&#xED;lio Ribas, 1819,
Gopouva, 07050-000 Guarulhos, SP. (11) 2408-2118. E-mail:
<email>francinepapaiordanou@gmail.com</email></corresp>
      </author-notes>
      <pub-date pub-type="epub-ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <!--Fake ppub date generated by PMC from publisher
							pub-date/@pub-type='epub-ppub' -->
      <pub-date pub-type="ppub">
        <season>Jul-Aug</season>
        <year>2015</year>
      </pub-date>
      <volume>90</volume>
      <issue>4</issue>
      <fpage>557</fpage>
      <lpage>560</lpage>
      <history>
        <date date-type="received">
          <day>08</day>
          <month>11</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>16</day>
          <month>12</month>
          <year>2013</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; 2015 by Anais Brasileiros de Dermatologia</copyright-statement>
        <license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc/4.0/">
          <license-p>This is an Open Access article distributed under the terms of the Creative
Commons Attribution Non-Commercial License which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the
original work is properly cited.</license-p>
        </license>
      </permissions>
      <abstract>
        <p>Severe cutaneous drug reactions include a wide spectrum of clinical manifestations
ranging from mild morbilliform cutaneous rash, to severe forms of hypersensitivity.
Special attention is given in this report to the acute generalized exanthematous
pustulosis (AGEP), induced in 90% of cases by the use of systemic drugs, especially
aminopenicillins and macrolides. The incidence of the disease is low, 1-5 cases per
million patients / year. The main differential diagnosis is Von Zumbusch's Pustular
Psoriasis. The prognosis is generally good and the disease self limited, after
withdrawal of the triggering drug. In this report the authors describe a case of
AGEP, triggered by ceftriaxone in a patient with psoriasis vulgaris.</p>
      </abstract>
      <kwd-group>
        <kwd>Drug hypersensitivity</kwd>
        <kwd>Exanthema</kwd>
        <kwd>Psoriasis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec sec-type="intro">
      <title>INTRODUCTION</title>
      <p>Cutaneous drug reactions encompass a wide spectrum of clinical manifestations that range
from mild morbilliform rash to severe forms of hypersensitivity<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r02" ref-type="bibr">2</xref></sup>.
Special attention is dedicated in this report to acute generalized exanthematous
pustulosis (AGEP), which in over 90% of cases is induced by the use of systemic drugs,
especially aminopenicillins and macrolides.<sup><xref rid="r01" ref-type="bibr">1</xref></sup><sup>,-</sup><sup><xref rid="r04" ref-type="bibr">4</xref></sup></p>
      <p>The term AGEP was first proposed by <italic>Beylot et al</italic>; later on
<italic>Roujeau et al</italic> reported a series of 63 cases of the disease, in study
published in 1991.<sup><xref rid="r01" ref-type="bibr">1</xref>,<xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup> The first
Brazilian case was described by Campbell and Furtado, who described how a patient
developed AGEP following the use of ampicillin.</p>
      <p>The incidence of the disease is 1 to 5 cases per million patients/year. The mean age of
patients is 56 years and both genders are affected, with discreet female
predominance.<sup><xref rid="r04" ref-type="bibr">4</xref></sup> The
etiopathogenesis is still not completely understood, although immune mechanisms mediated
by T cells and cytokines have the greatest amount of scientific evidence up to the
moment.<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup></p>
      <p>The main differential diagnosis is Von Zumbusch's Pustular Psoriasis, formerly regarded
as an AGEP variant, but clearly differentiated in more recent investigation (EuroScar
study).<sup><xref rid="r06" ref-type="bibr">6</xref></sup> Some criteria favor the
pustular psoriasis diagnosis - history of psoriasis, prolonged fever, pustular rash of
longer duration than in AGEP, absence of history of drug exposure and a differentiated
histopathological picture.<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r06" ref-type="bibr">6</xref></sup>
What makes diagnosis difficult is the fact that patients with psoriasis are more prone
to develop AGEP than healthy patients, an affirmation based on statistical data, by
means of a mechanism still unknown.<sup><xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref>,<xref rid="r07" ref-type="bibr">7</xref></sup></p>
      <p>The relationship established between the two nosological entities are the clinical
similarities, but there is evidence that they are distinct diseases, as cited above.</p>
      <p>In this report the authors describe an AGEP case triggered by ceftriaxone in a patient
with psoriasis vulgaris.</p>
    </sec>
    <sec>
      <title>CASE REPORT</title>
      <p>Male patient, 66 years old, from S&#xE3;o Paulo, SP, with psoriasis vulgaris antecedent and
previous treatment with acitretin. He was referred to the dermatology service due to the
sudden onset of exanthema on the trunk and limbs, after use of ceftriaxone for treatment
of erysipela. At first he was medicated with IV hydrocortisone, but even with the use of
corticosteroids the lesions worsened and progressed with millimeter-sized pustules. The
dermatological examination showed erythematous desquamative lesions on the trunk and
limbs associated with disseminated pustules, more abundant in flexural areas (<xref ref-type="fig" rid="f01">Figures 1</xref> and <xref ref-type="fig" rid="f02">2</xref>). Laboratory tests revealed only leukocytosis, without deviations.</p>
      <fig id="f01" orientation="portrait" position="float">
        <label>FIGURE 1</label>
        <caption>
          <p>Pustules measuring approximately 0.1 to 0.2mm and intense desquamation in
erythematous skin</p>
        </caption>
        <graphic xlink:href="abd-90-04-0557-g01"/>
      </fig>
      <fig id="f02" orientation="portrait" position="float">
        <label>FIGURE 2</label>
        <caption>
          <p>Detail of pustules concentrated in antecubital flexural region</p>
        </caption>
        <graphic xlink:href="abd-90-04-0557-g02"/>
      </fig>
      <p>The patient was hospitalized with diagnostic hypotheses of AGEP x generalized pustular
psoriasis. Ceftriaxone was suspended and a cutaneous biopsy was performed, while
introducing prednisone and antihistaminics orally.</p>
      <p>The histopathological examination showed evidence of psoriasiform spongiotic dermatitis,
with intense dermal edema and migration of neutrophils to the corneal layer. Correlating
the findings with the clinical picture, the final diagnosis was AGEP (<xref ref-type="fig" rid="f03">Figures 3</xref> and <xref ref-type="fig" rid="f04">4</xref>).</p>
      <fig id="f03" orientation="portrait" position="float">
        <label>FIGURE 3</label>
        <caption>
          <p>HE 100x. Epidermis with acanthosis, neutrophil migration and marked dermal
edema</p>
        </caption>
        <graphic xlink:href="abd-90-04-0557-g03"/>
      </fig>
      <fig id="f04" orientation="portrait" position="float">
        <label>FIGURE 4</label>
        <caption>
          <p>Detail of marked dermal edema and presence of eosinophils</p>
        </caption>
        <graphic xlink:href="abd-90-04-0557-g04"/>
      </fig>
      <p>The patient progressed with improved clinical picture and partial regression of the
exanthema, as well as total regression of pustules in 5 days. He was discharged and
remains under medical follow-up (<xref ref-type="fig" rid="f05">Figure 5</xref>).</p>
      <fig id="f05" orientation="portrait" position="float">
        <label>FIGURE 5</label>
        <caption>
          <p>Trunk of patient with intense desquamation on erythematous base</p>
        </caption>
        <graphic xlink:href="abd-90-04-0557-g05"/>
      </fig>
    </sec>
    <sec sec-type="discussion">
      <title>DISCUSSION</title>
      <p>The diagnosis of reaction to drugs is most times achieved after exclusion of other more
probable diagnostic possibilities. In this case, some factors made immediate diagnosis
difficult.</p>
      <p>One of the main triggers of pustular psoriasis in patients with psoriasis vulgaris or
even as the first manifestation of the disease is the untimely use of oral
corticosteroid therapy. Our patient was treated with IV hydrocortisone for exanthema and
progressed with pustulosis, but he had been medicated a few days before with
antimicrobial from one of the main classes related to AGEP.</p>
      <p>Some of the data suggest the AGEP diagnosis, but may not be considered as diagnostic
criteria in view of their specificity in the differentiation with pustular psoriasis,
still not tested in studies and not published in the literature.<sup><xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <list list-type="bullet">
        <list-item>
          <p>Abrupt onset of pustular rash, hours or a few days after use of medication</p>
        </list-item>
        <list-item>
          <p>Hundreds of millimeter-sized non-follicular pustules, permeated by erythema and
edema</p>
        </list-item>
        <list-item>
          <p>Leukocytosis with neutrophilia</p>
        </list-item>
        <list-item>
          <p>Pustule culture negative for bacteria</p>
        </list-item>
        <list-item>
          <p>Rapid resolution after drug suspension</p>
        </list-item>
      </list>
      <p>The histopathologic standards that favor the AGEP diagnosis are:</p>
      <list list-type="bullet">
        <list-item>
          <p>Spongiform subcorneal or intraepidermal pustules</p>
        </list-item>
        <list-item>
          <p>Eosinophils in the pustules or in the dermis</p>
        </list-item>
        <list-item>
          <p>Necrotic keratinocytes</p>
        </list-item>
        <list-item>
          <p>Neutrophilic infiltrate</p>
        </list-item>
        <list-item>
          <p>Absence of tortuous or dilated vessels</p>
        </list-item>
      </list>
      <p>In pustular psoriasis, the rash is usually monomorphic, lasts for a longer period of
time and is recurrent. It is less flexural than AGEP. Many times it is associated with
arthritis and regresses in a period of 10 to 14 days. Histology shows epidermal
hyperplasia, papillomatosis and acanthosis<sup><xref rid="r02" ref-type="bibr">2</xref>,<xref rid="r03" ref-type="bibr">3</xref></sup>. Other important
differential diagnoses are: staphylococcal scalded skin syndrome, septicemia by
staphylococcus aureus, bacterial folliculitis, subcorneal pustulosis, Stevens Johnson
syndrome, toxic epidermal necrolisis and drug reaction with eosinophilia and systemic
symptoms (DRESS).<sup><xref rid="r03" ref-type="bibr">3</xref>,<xref rid="r04" ref-type="bibr">4</xref>,<xref rid="r05" ref-type="bibr">5</xref></sup></p>
      <p>AGEP etiology is strongly associated with macrolides and beta-lactam based agents, but
other medications and even viral infections may be related (quinolones, sulfonamides,
terbinafine. antimalarials, calcium channel blockers, AINES, spider bites and infections
by parvovirus B19, cytomegalovirus, coxsackie B4 and mycoplasma pneumoniae).<sup><xref rid="r01" ref-type="bibr">1</xref>-<xref rid="r08" ref-type="bibr">8</xref></sup>
It is important to remember that the main AGEP-triggering drugs are different from the
main drugs implicated in the onset of other severe reactions, such as drug reaction with
eosinophilia and systemic symptoms (DRESS) and toxic epidermal necrolisis (TEN),
resulting mainly from the use of anticonvulsants, although antibiotics are also
implicated.</p>
      <p>The diagnosis is clinical, histopathologic, and in some cases the contact test, usually
performed 4-6 weeks after the clinical picture is resolved, may help. A positive test
may confirm the etiology, but a negative test does not exclude it.</p>
      <p>The prognosis is good and the disease self limited, after withdrawal of the triggering
drug, unless there is secondary infection of the lesions. A symptomatic treatment is
indicated for relief of pruritus and cutaneous inflammation (medium potency topical
corticosteroids 2x / day for 1 week), besides antiseptic solutions in the pustular phase
to prevent superinfection and emollients in the desquamative phase to reestablish the
cutaneous barrier. Only rare severe cases require hospitalization for hydration support
and electrolytic equilibrium.</p>
      <p>This report stresses the need to include AGEP as possible diagnosis of patient with
psoriasis presenting acute pustulosis, although generalized Von Zumbusch's Pustular
Psoriasis is more prevalent in this group of patients.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="conflict">
        <p>Conflict of Interest: None.</p>
      </fn>
      <fn fn-type="supported-by">
        <p>Financial Support: None.</p>
      </fn>
      <fn fn-type="other">
        <p><bold>How to cite this article:</bold> Sousa AS, Lara OACC, Papaiordanou F, Marchioro
GSS, Tebcherani A. Acute generalized exanthematous pustulosis x Von Zumbusch&#x2019;s
pustular psoriasis : A diagnostic challenge in a psoriatic patient. An Bras Dermatol.
2015;90(4):557-60.</p>
      </fn>
      <fn fn-type="other" id="fn01">
        <label>*</label>
        <p>Study carried out at the Complexo Hospitalar Padre Bento de Guarulhos (CHPBG) -
Guarulhos (SP), Brazil.</p>
      </fn>
    </fn-group>
    <ref-list>
      <title>REFERENCES</title>
      <ref id="r01">
        <label>1</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Beltraminelli</surname>
              <given-names>HS</given-names>
            </name>
            <name>
              <surname>Lerch</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Arnold</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Bircher</surname>
              <given-names>AJ</given-names>
            </name>
            <name>
              <surname>Haeusermann</surname>
              <given-names>P</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis induced by the antifungal
terbinafine: case report and review of the literature</article-title>
          <source>Br J Dermatol</source>
          <year>2005</year>
          <volume>152</volume>
          <fpage>780</fpage>
          <lpage>783</lpage>
          <pub-id pub-id-type="pmid">15840114</pub-id>
        </element-citation>
      </ref>
      <ref id="r02">
        <label>2</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Criado</surname>
              <given-names>PRi</given-names>
            </name>
            <name>
              <surname>Criado</surname>
              <given-names>RFJ</given-names>
            </name>
            <name>
              <surname>Vasconcellos</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ramos</surname>
              <given-names>RO</given-names>
            </name>
            <name>
              <surname>Gon&#xE7;alves</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Severe cutaneous adverse drug reactions - relevant aspects to
diagnosis and treatment - Part II</article-title>
          <source>An. Bras Dermatol</source>
          <year>2004</year>
          <volume>79</volume>
          <fpage>587</fpage>
          <lpage>601</lpage>
        </element-citation>
      </ref>
      <ref id="r03">
        <label>3</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Belda</surname>
              <given-names>W</given-names>
              <suffix>Junior</suffix>
            </name>
            <name>
              <surname>Ferolla</surname>
              <given-names>AC</given-names>
            </name>
          </person-group>
          <article-title>Acute generalized exanthematous pustulosis (AGEP). Case
report</article-title>
          <source>Rev Inst Med Trop Sao Paulo</source>
          <year>2005</year>
          <volume>47</volume>
          <fpage>171</fpage>
          <lpage>176</lpage>
          <pub-id pub-id-type="pmid">16021293</pub-id>
        </element-citation>
      </ref>
      <ref id="r04">
        <label>4</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Sidoroff</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <source>Acute generalized exanthematous pustulosis (AGEP)</source>
          <person-group person-group-type="author">
            <collab>UpToDate.</collab>
            <name>
              <surname>Mockenhaupt</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <publisher-loc>Waltham, MA</publisher-loc>
          <publisher-name>UpToDate</publisher-name>
          <year>2013</year>
        </element-citation>
      </ref>
      <ref id="r05">
        <label>5</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Buffon</surname>
              <given-names>LP</given-names>
            </name>
            <name>
              <surname>Leal</surname>
              <given-names>R</given-names>
            </name>
          </person-group>
          <article-title>Acute Generalized Exanthematous Pustulosis (AGEP)</article-title>
          <source>An Bras Dermatol</source>
          <year>2002</year>
          <volume>77</volume>
          <fpage>223</fpage>
          <lpage>228</lpage>
        </element-citation>
      </ref>
      <ref id="r06">
        <label>6</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Sidoroff</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Dunant</surname>
              <given-names>A</given-names>
            </name>
            <name>
              <surname>Viboud</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Halevy</surname>
              <given-names>S</given-names>
            </name>
            <name>
              <surname>Bavinck</surname>
              <given-names>JN</given-names>
            </name>
            <name>
              <surname>Naldi</surname>
              <given-names>L</given-names>
            </name>
            <etal/>
          </person-group>
          <article-title>Risk factors for acute generalized exanthematous pustulosis (AGEP) -
results of a multinational case-control study (EuroSCAR)</article-title>
          <source>Br J Dermatol</source>
          <year>2007</year>
          <volume>157</volume>
          <fpage>989</fpage>
          <lpage>996</lpage>
          <pub-id pub-id-type="pmid">17854366</pub-id>
        </element-citation>
      </ref>
      <ref id="r07">
        <label>7</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Razera</surname>
              <given-names>F</given-names>
            </name>
            <name>
              <surname>Olm</surname>
              <given-names>GS</given-names>
            </name>
            <name>
              <surname>Bonamigo</surname>
              <given-names>RR</given-names>
            </name>
          </person-group>
          <article-title>Dermatoses neutrof&#xED;licas: parte II</article-title>
          <source>An Bras Dermatol</source>
          <year>2011</year>
          <volume>86</volume>
          <fpage>195</fpage>
          <lpage>209</lpage>
          <pub-id pub-id-type="pmid">21603801</pub-id>
        </element-citation>
      </ref>
      <ref id="r08">
        <label>8</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Revuz</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Valeyrie-Allanore</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <chapter-title>Urticarias, erythemas and purpuras</chapter-title>
          <person-group person-group-type="editor">
            <name>
              <surname>Bolognia</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Jorizzo</surname>
              <given-names>JL</given-names>
            </name>
            <name>
              <surname>Rapini</surname>
              <given-names>RP</given-names>
            </name>
          </person-group>
          <source>Bolognia Textbook of Dermatology</source>
          <edition>2nd ed</edition>
          <publisher-loc>Spain</publisher-loc>
          <publisher-name>Mosby Elsevier publishing</publisher-name>
          <fpage>342</fpage>
          <lpage>343</lpage>
          <year>2008</year>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
